# Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

> **NCT06767774** · PHASE4 · RECRUITING · sponsor: **Korea University Anam Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- ASCVD
- Diabetes
- Statin

## Interventions

- **DRUG:** Combination therapy
- **DRUG:** High intensity statin monotherapy

## Key facts

- **NCT ID:** NCT06767774
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-25
- **Primary completion:** 2029-08-31
- **Final completion:** 2030-01-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06767774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06767774, "Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06767774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*